Clarivate Announces Change to its Board of Directors
Clarivate Plc (NYSE: CCC) announced the resignation of Michael S. Klein from its Board of Directors, effective immediately. Klein was a pivotal figure, having previously served as Chairman of Churchill Capital Corp, which merged with Clarivate in May 2019. Jerre Stead, CEO and Executive Chairman, expressed gratitude for Klein's contributions over the past years. Following his departure, the board will consist of 12 members. Clarivate continues to lead in providing innovative solutions to enhance the lifecycle of innovation, aiding clients in scientific and healthcare fields.
- Klein's contributions have been acknowledged, suggesting a solid leadership legacy.
- The board now has room for new perspectives with the departure of one member.
- The departure of a board member introduces uncertainty in leadership continuity.
- Klein's prior leadership experience may create a gap in expertise.
LONDON, Nov. 2, 2020 /PRNewswire/ -- Clarivate Plc (NYSE: CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Michael S. Klein, a member of the board of directors, has informed the Company of his decision to step down from the board. Mr. Klein previously served as Chairman of Churchill Capital Corp, a special purpose acquisition company (SPAC), which merged with Clarivate in May 2019.
Jerre Stead, Executive Chairman and CEO said: "On behalf of the entire company and the Board of Directors, I am very grateful for Michael's contributions and guidance over the past couple years. Clarivate has benefited significantly from Michael's business and leadership expertise. We wish him well with his future endeavors."
With Mr. Klein's departure, the Clarivate Board will consist of 12 members.
About Clarivate
Clarivate™ is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world's most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions. Covering scientific and academic research, pharmaceutical, biotech and healthcare intelligence and intellectual property services, we help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise. For more information, please visit clarivate.com.
Category: Board of Director change
Source: Clarivate Plc
View original content to download multimedia:http://www.prnewswire.com/news-releases/clarivate-announces-change-to-its-board-of-directors-301164464.html
SOURCE Clarivate Plc
FAQ
What led to Michael S. Klein's resignation from the board of Clarivate?
What impact might Klein's departure have on Clarivate's future?
How many members are currently on the board of Clarivate?
Who is the current Executive Chairman and CEO of Clarivate?
When did Churchill Capital Corp merge with Clarivate?
